3 ms·
It’s basically a posterior grant, a price paid out to the company who invented the drug. Eventually the patent will expire and the drug will become cheap for
by konschubert 3y ago
It’s basically a posterior grant, a price paid out to the company who invented the drug.
Eventually the patent will expire and the drug will become cheap for society.
In the meantime, the high payout will encourage the development of treatments for other rare diseases